July 26, Renhe pharmaceutical sales continue. According to the Shenzhen Exchange published data, the same day Citic Securities Beijing Wai Street Sales department continued to sell the bulk trading platform and pharmaceutical 1.3 million shares, the transaction price of 14.20 Yuan. On the previous trading day, July 23, the sales department has significantly reduced the 12.2 million shares. Two trading days, the sales department sold a total of 13.5 million shares, the total transaction amount of nearly 190 million yuan. One-year earnings 80% SSE bulk trading data, July 26, 1.3 million shares of benevolence and pharmaceutical shares were traded. Sold for CITIC Securities Beijing outside the main Street sales department, transaction price of 14.20 yuan, the minimum of 14.28 yuan on the day is also cheaper. The same day, benevolence and pharmaceutical industry turned red after the low, the stock price of the highest 15.50 yuan, finally closed at 15.35 Yuan, up 3.23%. The bulk trading platform shows that July 23, benevolence and pharmaceutical industry occurred 6 transactions, the largest one for 4.1 million shares, the smallest a sum of 500,000 shares, the total turnover of 12.2 million shares, the total amount of transactions up to 170.8 million yuan, the seller is Citic Securities Beijing Wai Street Securities Business Department, the transaction price is 14 yuan/share, Renhe Pharmaceutical Business Day closing price of 14.87 yuan/share. July 22, 2009, Renhe Pharmaceutical Industry directed additional completed, to 11.84 yuan/share of the price of the total issue of 60 million shares, of which Shanghai Central China industrial subscription 10 million shares, Beijing International Trust subscription 9 million shares, market participants said, have the ability to throw so many stakes in the only two, From the position of the sales department, Beijing International Trust is the most likely. The cost of 11.84 yuan, and then the 2009 years of Benevolence and medicine "10 to 5 send 3 yuan" profit distribution scheme, to July 23, 2010 when the lifting of the ban, directed additional shareholder's book returns are more than 80%. Some shareholders are very injured "80% of the level of income is much higher than the same period of two-tier market investment," a similar number of participants in the direction of private placement in Shanghai, told reporters, compared to more than a half of the investment "specialist", benevolence and pharmaceutical targeted additional income is very high. June 10, 2009, Beijing Oriental announced the direction of additional programs to 2.4 yuan/share of the price raised 12 billion yuan. June 11, 2010, the relevant shares lifted, the day of the shares closed at 3.30 yuan, the yield of 37%. Even worse is the real estate company directional additional. In the 2009, real estate companies implemented directional additional issuance, and this year's property-sector adjustment made the participating investors "injured". July 14, Poly Real Estate 2009 Directional additional shares in the 350 million shares lifted, closed at 11.31 yuan, in accordance with 10 to send 3 1 dividend scheme, in addition to the right to ex-dividend price should be around 14.80 yuan, compared to 24.12 yuan of additional price fell 39%. August 2009, the Golden Land Group announced the directional additional, to 14 yuan/share of the price of 302.57 million shares, up to now in addition to the right to the price of about 15.98 yuan, book income of about 14%. "The biggest advantage of directional placement is that you can enjoy a 90 percent purchase price, but you need to lock in for a year, so the benefits will be affected by this big adjustment this year." "The private equity told the reporter, investment directional additional, the key is to see whether the company can achieve smooth development after raising capital." Chen Jiwu, general manager of Shanghai Kaishi Investment, said: "Take a year!" Without looking at fundamentals, can you feel at ease? ”
The content source of this page is from Internet, which doesn't represent Alibaba Cloud's opinion;
products and services mentioned on that page don't have any relationship with Alibaba Cloud. If the
content of the page makes you feel confusing, please write us an email, we will handle the problem
within 5 days after receiving your email.
If you find any instances of plagiarism from the community, please send an email to:
info-contact@alibabacloud.com
and provide relevant evidence. A staff member will contact you within 5 working days.